InvestSMART

Sonic Healthcare Limited (ASX:SHL)

ALERT: Price-sensitive ASX Announcement for SHL
Current share price for SHL : $20.060 -1.18 (-5.56%)+
Announcement
Release
19 Feb 2026 8:49AM
Price at Release
$21.240
Full Release
download
Summary
Sonic Healthcare Limited reported a strong financial performance for the half-year ended 31 December 2025, with significant revenue growth and improved earnings per share. The company achieved a 17% increase in revenue to A$5,445 million and an 11% rise in net profit to A$262 million, demonstrating effective cost control and operational efficiency. The EBITDA increased by 10% to A$907 million, supported by organic growth and synergies from acquisitions, especially in Germany and Switzerland. The US operations are undergoing a review to address low growth and restructuring costs. Sonic Healthcare is maintaining its full-year FY 2026 earnings guidance and progressive dividend policy, with a 1 cent increase in interim dividend. The company continues to focus on growth opportunities and integration synergies across its global operations.
Key Points
  • Sonic Healthcare's revenue increased by 17% to A$5,445 million.
  • Net profit rose by 11% to A$262 million.
  • EBITDA grew by 10% to A$907 million.
  • Maintained full-year FY 2026 earnings guidance.
  • Ongoing review and restructuring in the US operations.
  • Strong performance in Germany and Switzerland.
  • Integration of recent acquisitions progressing well.
  • Progressive dividend policy with a 1 cent increase.
  • Continued focus on cost control and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.